S&CO Inc. Takes $2.66 Million Position in Danaher Corporation $DHR

S&CO Inc. bought a new stake in shares of Danaher Corporation (NYSE:DHR) during the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm bought 13,989 shares of the conglomerate’s stock, valued at approximately $2,664,000.

Several other hedge funds have also added to or reduced their stakes in the business. Northwestern Mutual Wealth Management Co. lifted its stake in shares of Danaher by 303.7% in the 4th quarter. Northwestern Mutual Wealth Management Co. now owns 248,020 shares of the conglomerate’s stock valued at $56,777,000 after acquiring an additional 186,584 shares during the last quarter. Legal & General Group Plc grew its position in Danaher by 1.0% during the 4th quarter. Legal & General Group Plc now owns 4,495,287 shares of the conglomerate’s stock worth $1,029,061,000 after acquiring an additional 43,169 shares during the last quarter. Zurcher Kantonalbank Zurich Cantonalbank grew its position in Danaher by 51.5% during the 4th quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 271,734 shares of the conglomerate’s stock worth $62,205,000 after acquiring an additional 92,323 shares during the last quarter. Mirae Asset Global Investments Co. Ltd. increased its stake in Danaher by 41.8% in the 4th quarter. Mirae Asset Global Investments Co. Ltd. now owns 168,163 shares of the conglomerate’s stock worth $38,496,000 after purchasing an additional 49,559 shares during the period. Finally, Advisors Capital Management LLC increased its stake in Danaher by 14.0% in the 4th quarter. Advisors Capital Management LLC now owns 54,845 shares of the conglomerate’s stock worth $12,555,000 after purchasing an additional 6,720 shares during the period. 79.05% of the stock is owned by institutional investors.

Danaher Price Performance

DHR opened at $202.51 on Friday. The company has a debt-to-equity ratio of 0.48, a quick ratio of 1.25 and a current ratio of 1.65. Danaher Corporation has a 52-week low of $160.93 and a 52-week high of $242.80. The stock has a market capitalization of $142.37 billion, a PE ratio of 35.97, a price-to-earnings-growth ratio of 2.52 and a beta of 0.78. The stock’s 50 day moving average price is $193.14 and its 200-day moving average price is $193.21.

Danaher (NYSE:DHR) last announced its quarterly earnings results on Monday, July 20th. The conglomerate reported $1.94 EPS for the quarter, topping analysts’ consensus estimates of $1.85 by $0.09. Danaher had a return on equity of 11.04% and a net margin of 15.95%.The company had revenue of $6.26 billion during the quarter, compared to analyst estimates of $6.12 billion. During the same quarter last year, the firm posted $0.77 earnings per share. The firm’s revenue was up 5.5% on a year-over-year basis. On average, equities research analysts predict that Danaher Corporation will post 8.53 EPS for the current year.

Analyst Upgrades and Downgrades

A number of research firms have recently weighed in on DHR. Deutsche Bank Aktiengesellschaft reissued a “buy” rating and set a $240.00 price objective on shares of Danaher in a research note on Wednesday, July 22nd. Citigroup began coverage on shares of Danaher in a research report on Tuesday, May 26th. They set a “buy” rating and a $230.00 price target for the company. Jefferies Financial Group reissued a “buy” rating and issued a $245.00 price target on shares of Danaher in a report on Tuesday, April 21st. Morgan Stanley decreased their price objective on shares of Danaher from $270.00 to $255.00 and set an “overweight” rating on the stock in a research report on Wednesday, April 22nd. Finally, DZ Bank initiated coverage on shares of Danaher in a research note on Wednesday, June 3rd. They set a “buy” rating and a $210.00 price objective for the company. One equities research analyst has rated the stock with a Strong Buy rating, nineteen have given a Buy rating and five have assigned a Hold rating to the stock. According to data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $228.91.

About Danaher

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.